How To Check Mukka Proteins IPO Allotment Status
Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Congratulations!
You have successfully subscribed.

The Mukka Proteins IPO concluded on March 4 with a robust subscription rate of 136.99%. The Mukka Proteins IPO allotment status is set to be finalised today, March 5.

If you applied for the IPO, here is how you can check the Mukka Proteins IPO allotment status.

Checking IPO Allotment Status on Registrar's Website:

Follow these steps to check the Mukka Proteins IPO allotment status

  1. Visit the registrar's website.
  2. Click on "Company Selection" and choose "Mukka Proteins" from the dropdown menu.
  3. Then you can enter your PAN, application number, or Demat.
  4. Enter the captcha and click Submit to retrieve the Mukka Proteins IPO allotment status

Checking IPO Allotment Status on BSE:

  1. Go to the BSE website.
  2. Click on the ‘Equity' section and select "Mukka Proteins" from the dropdown menu.
  3. Enter your application number or PAN.
  4. Click on the ‘Search' button.
  5. The result will show the number of shares allotted to you.

If all the details are entered correctly and the allotment has been finalised, the Mukka Proteins IPO allotment status will be visible.

See also: Why IPO-Ready Ullu Is In Trouble Over Some Of Its Adult Content

Mukka Proteins IPO Subscription Status

The ₹224 crore IPO, witnessed significant investor interest, with bids received for 7,67,16,18,055 shares against the 5,60,00,435 shares on offer. The retail quota saw a remarkable subscription rate of 58.52 times, while non-institutional investors (NIIs) subscribed 250.38 times and qualified institutional buyers (QIBs) 189.28 times.

Mukka Proteins IPO Details

Launched for subscription on February 29, the Mukka Proteins IPO was priced in the range of ₹26-28 per share. The IPO allotment is scheduled for March 5, with listing on both the NSE and BSE slated for March 7, 2024.

Mukka Proteins’ IPO comprised a fresh issue of up to 8 crore equity shares, aggregating to ₹224 crore, with no Offer For Sale (OFS) component. The company plans to utilize ₹120 crore of the proceeds for working capital requirements and up to ₹10 crore for investment in its associate, Ento Proteins, to fund its working capital needs, along with general corporate purposes.

Mukka Proteins IPO GMP

Mukka Proteins IPO GMP is said to be at around ₹35, suggesting a 125% anticipated listing gain from the issue price.  It’s important to note that while IPO GMPs can offer a glimpse into market sentiment regarding an IPO, they shouldn’t be the sole determinant of the stock’s performance upon listing.

Read Next: Tata Motors Board Approves Demerger: Here’s What It Means For Shareholders

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Comments
Loading...
NewsIPOsMukka Proteins